Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionVersant Capital Management, Inc
Latest Disclosed Ownership1,066 shares
Latest Disclosed Value $ 476,012
Versant Capital Management, Inc reports 53.16% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 6, 2026 - Versant Capital Management, Inc filed a 13F-HR form disclosing ownership of 1,066 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $476,012 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 696 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 53.16% during the quarter. The current value of the position is $470,895 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 1,066 370 53.16 476 51.11 0.0469
2026-01-08 2025-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 696 478 219.27 316 270.59 0.0396
2025-10-27 2025-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 218 -456 -67.66 85 -71.67 0.0116
2025-07-07 2025-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 674 47 7.50 300 -0.99 0.0455
2025-04-03 2025-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 627 297 90.00 304 129.55 0.0510
2025-01-03 2024-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 330 169 104.97 133 78.38 0.0286
2024-10-07 2024-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 161 29 21.97 75 21.31 0.0171
2024-07-08 2024-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 132 98 288.24 62 335.71 0.0157
2024-04-03 2024-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 34 0 0.00 14 7.69 0.0041
2024-01-08 2023-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 34 0 0.00 14 18.18 0.0041
2023-10-12 2023-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 34 0 0.00 12 0.00 0.0038
2023-07-10 2023-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 34 10 41.67 12 57.14 0.0038
2023-04-10 2023-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 0 0.00 8 16.67 0.0025
2023-01-25 2022-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 0 0.00 7 -14.29 0.0025
2022-12-30 2022-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 0 0.00 7 0.00 0.0027
2022-08-02 2022-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 0 0.00 7 16.67 0.0026
2022-04-29 2022-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 0 0.00 6 20.00 0.0019
2022-01-06 2021-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 24 -7 -22.58 5 -16.67 0.0016
2021-10-29 2021-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 31 -51 -62.20 6 -64.71 0.0021
2021-07-22 2021-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 82 13 18.84 17 13.33 0.0063
2021-04-27 2021-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 69 43 165.38 15 150.00 0.0055
2021-02-08 2020-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 26 0 0.00 6 -14.29 0.0024
2020-11-02 2020-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 26 0 0.00 7 0.00 0.0031
2020-07-16 2020-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 26 0 0.00 7 16.67 0.0032
2020-04-17 2020-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 26 3 13.04 6 20.00 0.0032
2020-01-28 2019-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 23 0 0.00 5 66.67 0.0025
2019-10-18 2019-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 23 -12 -34.29 3 -50.00 0.0014
2019-07-16 2019-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 35 -26 -42.62 6 -45.45 0.0027
2019-04-23 2019-03-31 13F/A-1 VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 11 10.00 0.0047
2019-04-23 2019-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 11 11
2019-01-28 2018-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 10 -9.09 0.0046
2018-10-12 2018-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 11 10.00 0.0045
2018-07-06 2018-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 10 11.11 0.0042
2018-04-19 2018-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 9 0.00 0.0037
2018-04-18 2017-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 9 0.00 0.0036
2018-04-23 2017-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 9 28.57 0.0049
2018-04-23 2017-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 7 16.67 0.0039
2018-04-23 2017-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 0 0.00 6 50.00 0.0033
2018-04-23 2016-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 61 -52 -46.02 4 -55.56 0.0023
2018-04-23 2016-09-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 113 15 15.31 9 12.50 0.0051
2018-04-23 2016-06-30 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 98 0 0.00 8 14.29 0.0047
2018-04-23 2016-03-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 98 0 0.00 7 -41.67 0.0042
2018-04-23 2015-12-31 13F VERTEX PHARMACEUTICALS IN Stock 92532F100 98 98 12 0.0075
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.